These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15616031)

  • 1. Nitrergic neurodegeneration in cerebral arteries of streptozotocin-induced diabetic rats: a new insight into diabetic stroke.
    Cellek S; Anderson PN; Foxwell NA
    Diabetes; 2005 Jan; 54(1):212-9. PubMed ID: 15616031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats.
    Cellek S; Foxwell NA; Moncada S
    Diabetes; 2003 Sep; 52(9):2353-62. PubMed ID: 12941776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic action of advanced glycation end products and endogenous nitric oxide leads to neuronal apoptosis in vitro: a new insight into selective nitrergic neuropathy in diabetes.
    Cellek S; Qu W; Schmidt AM; Moncada S
    Diabetologia; 2004 Feb; 47(2):331-9. PubMed ID: 14676945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point of NO return for nitrergic nerves in diabetes: a new insight into diabetic complications.
    Cellek S
    Curr Pharm Des; 2004; 10(29):3683-95. PubMed ID: 15579064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon.
    Cellek S; Rodrigo J; Lobos E; Fernández P; Serrano J; Moncada S
    Br J Pharmacol; 1999 Dec; 128(8):1804-12. PubMed ID: 10588937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enalapril prevents impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in diabetic rats.
    Trauernicht AK; Sun H; Patel KP; Mayhan WG
    Stroke; 2003 Nov; 34(11):2698-703. PubMed ID: 14563973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of nitrergic-mediated relaxation of rat isolated duodenum by experimental diabetes.
    Martinez-Cuesta MA; Massuda H; Whittle BJ; Moncada S
    Br J Pharmacol; 1995 Mar; 114(5):919-24. PubMed ID: 7540094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in perivascular innervation function in mesenteric arteries from offspring of diabetic rats.
    de Queiroz DB; Sastre E; Caracuel L; Callejo M; Xavier FE; Blanco-Rivero J; Balfagón G
    Br J Pharmacol; 2015 Oct; 172(19):4699-713. PubMed ID: 26177571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presynaptic prostaglandin E2 EP1-receptor facilitation of cerebral nitrergic neurogenic vasodilation.
    Jadhav V; Jabre A; Chen MF; Lee TJ
    Stroke; 2009 Jan; 40(1):261-9. PubMed ID: 18948615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced nitric oxide-mediated relaxation and endothelial nitric oxide synthase expression in the tail arteries of streptozotocin-induced diabetic rats.
    Mokhtar SS; Vanhoutte PM; Leung SW; Suppian R; Yusof MI; Rasool AH
    Eur J Pharmacol; 2016 Feb; 773():78-84. PubMed ID: 26825543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide as a potential bridge between the metabolic and vascular hypotheses of diabetic neuropathy.
    Stevens MJ
    Diabet Med; 1995 Apr; 12(4):292-5. PubMed ID: 7600740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase activity and expression in experimental diabetic neuropathy.
    Zochodne DW; Verge VM; Cheng C; Höke A; Jolley C; Thomsen K; Rubin I; Lauritzen M
    J Neuropathol Exp Neurol; 2000 Sep; 59(9):798-807. PubMed ID: 11005260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms underlying reduced P2Y(1) -receptor-mediated relaxation in superior mesenteric arteries from long-term streptozotocin-induced diabetic rats.
    Ishida K; Matsumoto T; Taguchi K; Kamata K; Kobayashi T
    Acta Physiol (Oxf); 2013 Jan; 207(1):130-41. PubMed ID: 22759594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes induces sex-dependent changes in neuronal nitric oxide synthase dimerization and function in the rat gastric antrum.
    Gangula PR; Maner WL; Micci MA; Garfield RE; Pasricha PJ
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G725-33. PubMed ID: 17347455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The calpain inhibitor, A-705253, corrects penile nitrergic nerve dysfunction in diabetic mice.
    Nangle MR; Cotter MA; Cameron NE
    Eur J Pharmacol; 2006 May; 538(1-3):148-53. PubMed ID: 16650403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-targeted mice reveal a critical role for inducible nitric oxide synthase in vascular dysfunction during diabetes.
    Gunnett CA; Heistad DD; Faraci FM
    Stroke; 2003 Dec; 34(12):2970-4. PubMed ID: 14657549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide: from basic research on isolated blood vessels to clinical relevance in diabetes.
    Furchgott RF
    An R Acad Nac Med (Madr); 1998; 115(2):317-31. PubMed ID: 9882827
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrovascular disease of coronaries and cerebral arteries in streptozotocin-induced diabetic rats. A controlled, comparative study.
    Mavrikakis ME; Sfikakis PP; Kontoyannis D; Horti M; Kittas C; Koutras DA; Raptis SA
    Exp Clin Endocrinol Diabetes; 1998; 106(1):35-40. PubMed ID: 9516057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin reversal of impaired nitrergic transmission in the anococcygeus muscle from diabetic rats.
    Way KJ; Reid JJ
    Pharmacology; 1999 Sep; 59(3):115-26. PubMed ID: 10450066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of iNOS restricts functional activity of both eNOS and nNOS in pig cerebral artery.
    Mathewson AM; Wadsworth RM
    Nitric Oxide; 2004 Dec; 11(4):331-9. PubMed ID: 15604045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.